What does PharmacyLive pricing mean for a clinic P&L?

You can plan patient program structure: which SKUs drive volume, expected refill cadence, and the price points your market supports. What you cannot plan up front with a PharmacyLive portal is the COGS number itself, because your compounder controls catalog pricing per deployment. That gap matters most for high-volume GLP-1 programs, where a small per-vial difference multiplied across hundreds of monthly refills swings the bottom line. Before margin depends on it, ask your pharmacy rep for written per-vial cost on your top three SKUs and confirm whether the rate is fixed or subject to renegotiation at volume tiers.

Also clarify how ancillary costs hit the P&L. If shipping, cold-chain handling, or payment processing are billed separately from the drug line, the headline per-vial rate understates true landed cost. Build your margin model on the all-in number per vial delivered, not the catalog price alone, so your patient pricing protects the spread you actually need.

If one compounder covers your entire formulary and their PharmacyLive portal shows stable rates you trust, pharmacy-controlled pricing may be sufficient. Your ops team learns one portal, one price book, and one relationship. The P&L risk rises when you add a second compounder with its own PharmacyLive instance, because COGS now lives in two portals with no consolidated view.

Fizy Health puts buyer-side economics on the clinic P&L: resolved per-vial 503A cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment. Clinics that batch refills across multiple partners can model margin from numbers visible the same day they sign up, instead of reconciling pharmacy-by-pharmacy portal rates after the fact.